Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Nicholas Kitchin

Nicholas Kitchin

Senior Director in Pfizer’s Vaccine Clinical Research UK

Katalin Kariko

Katalin Kariko

Adjunct Professor of Neurosurgery USA

Anthony S. Fauci

Anthony S. Fauci

M.D. Former NIAID Director USA

Dr FionaCulley

Dr FionaCulley

Faculty of Medicine, National Heart & Lung Institute UK



Co-Director of the Institute of Infection UK

Prof. Emmanuelle Charpentier

Prof. Emmanuelle Charpentier

The Max Planck Director France

Recommended Global Vaccines Webinars & Conferences

Europe & UK
Asia Pacific & Middle East


About Conference

It is our pleasure to announce the 44th Global Summit and Expo on Vaccines & Immunology, scheduled to take place in the vibrant city of Montreal, Canada, on August 01-02. This groundbreaking conference aims to bring together leading researchers, clinicians, and industry experts to explore the latest advancements in vaccine development and immunology.

Conference Highlights: Immerse yourself in two days of dynamic sessions covering diverse topics such as cutting-edge vaccine technologies, immunotherapies, and breakthroughs in understanding host-pathogen interactions. The conference will delve into emerging infectious diseases, emphasizing strategies for rapid response and global health implications.

Session & Tracks

Submit your groundbreaking research and contribute to the rich tapestry of discussions. The call for abstracts is now open, offering an opportunity to showcase your work on an international stage.

Session 1: Vaccine Development and Design

Session 2: Immunopathology and Host-Pathogen Interactions

Session 3: Emerging Infectious Diseases and Global Health

Session 4: Innovative Immunotherapies

Session 5: Vaccine Safety and Adverse Event Monitoring

Session 6: Public Health and Vaccination Programs

Session 7: Immunogenetics and Personalized Vaccinology

Session 8: Innate and Adaptive Immune Responses

Session 9: Vaccines for Non-Communicable Diseases

Session 10: Immunization in Special Populations

Session 11: Vaccination Strategies for Vector-Borne Diseases

Session 12: Ethical and Societal Aspects of Vaccination

Session 13: Immunodiagnostics and Monitoring Immune Responses

Session 14: Vaccine Economics and Market Access

Session 15: Vaccine Education and Advocacy

Market Analysis

The 44th Global Summit and Expo on Vaccines & Immunology, slated for August 01-02, 2024, in Montreal, Canada, promises to be a focal point for the dynamic and promising landscape of the vaccines and immunology sector. As the global healthcare landscape evolves, the market analysis for this summit unveils key trends and opportunities in the field.The global vaccine market is experiencing remarkable growth, driven by heightened awareness of preventive healthcare, advancements in vaccine development technologies, and an increasing incidence of infectious diseases worldwide. With Montreal hosting this summit, it becomes a strategic hub for industry stakeholders, researchers, and policymakers to converge, exchange insights, and propel the field forward.

Technological innovations in immunology are at the forefront of discussions. The summit is expected to highlight groundbreaking technologies such as mRNA vaccines, personalized vaccinology, and the integration of artificial intelligence in immunological research. These advancements not only underscore the progress in vaccine development but also open new avenues for targeted and efficient immunotherapies.

The surge in research and development investments is a notable trend. Governments, pharmaceutical companies, and research institutions are channeling substantial resources into exploring novel avenues for vaccines and immunotherapies. This investment trend is anticipated to be a focal point, providing a comprehensive overview of the financial landscape and its implications for future developments.The summit is poised to address global health imperatives, with a particular emphasis on international immunization programs. Discussions will encompass vaccination strategies, access to vaccines in low-income countries, and collaborative efforts to combat global health challenges. Such deliberations are crucial in fostering a holistic approach to healthcare on a global scale.

Beyond traditional vaccines, the market analysis will likely delve into the burgeoning trends in immunotherapies. Monoclonal antibodies, cellular therapies, and other innovative interventions are reshaping the immunological intervention landscape. Understanding these trends is vital for industry players, researchers, and healthcare providers to stay abreast of the evolving market dynamics.Regulatory considerations will also take center stage, addressing the complexities of ensuring the safety and efficacy of vaccines. The summit is expected to provide insights into evolving regulatory frameworks, compliance challenges, and strategies to navigate this intricate landscape successfully.

In essence, the market analysis for the 44th Global Summit and Expo on Vaccines & Immunology anticipates not only showcasing the current state of the industry but also charting a course for its future. The discussions, collaborations, and insights generated during the summit are poised to have a lasting impact on the trajectory of vaccines and immunology globally.

Societies & Associations

  1. International Society for Vaccines (ISV):  ISV is a global organization dedicated to promoting the understanding, development, and use of vaccines for the prevention of infectious and non-infectious diseases. Members include researchers, clinicians, and industry professionals.

  2. American Association of Immunologists (AAI): AAI is a professional association for immunologists, providing a platform for researchers, educators, and clinicians to collaborate and advance the field of immunology.

  3. World Health Organization (WHO): As a leading global health organization, WHO plays a vital role in shaping international immunization policies, guidelines, and initiatives. Their involvement in the conference may offer insights into global health perspectives.

  4. European Vaccine Initiative (EVI): EVI is a non-profit organization dedicated to accelerating the development of vaccines for infectious diseases with a focus on diseases affecting low- and middle-income countries. Their participation could bring a global perspective to the conference.

  5. Canadian Immunization Research Network (CIRN): CIRN is a Canadian research network focused on improving the understanding and effectiveness of vaccines. Given the conference's location in Montreal, CIRN's involvement may provide a local and national context to discussions.

  6. Vaccine Education Center at Children's Hospital of Philadelphia (CHOP): The Vaccine Education Center at CHOP is known for its efforts in providing accurate and up-to-date information about vaccines. Their participation may contribute to discussions on vaccine education and advocacy.

  7. International Association of Immunization Managers (IAIM): IAIM is a global organization that brings together immunization program managers to share best practices, strategies, and innovations in vaccine delivery. Their involvement could offer insights into immunization program management.

  8. Canadian Immunization Committee (CIC): CIC is a committee within the Public Health Agency of Canada, providing recommendations on immunization policy. Their participation may provide a link between research discussed at the conference and Canadian immunization practices.

  9. Association of Immunization Managers (AIM): AIM is an organization focused on supporting immunization program managers in the United States. Their participation may contribute to discussions on immunization strategies and policies.

These societies and associations, among others, are likely to play an integral role in shaping the discourse, fostering collaboration, and ensuring that the 44th Global Summit and Expo on Vaccines & Immunology Conference reflects the diverse perspectives and expertise in the field.

To Collaborate Scientific Professionals around the World

Conference Date August 01-02, 2024

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Virology & Antiviral Research Journal of Infectious Diseases & Therapy Journal of Molecular Immunology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by